Mechanism of absorption of Drugs

Absorption of Drugs

• Absorption concerns the process of entry of drug in to systemic circulation from site of administration.

•The rate and extent of absorption depend on:

-the environment where the drug is absorbed

-chemical characteristics of drug

-route of administration (which influence bioavailability)

• The route of administration other than intravenous may result in partial absorption and lower bioavailability.

(A) Mechanism of absorption of drug from GIT

• Depending upon their chemical properties , drugs may be absorbed from GI tract by passive diffusion, facilitated diffusion, active transport or endocytosis.

(1) Passive diffusion :

• In this drug move from area of high concentration to area of lower concentration.

- also known as non-ionic diffusion

- The driving force for this process is concentration or electrochemical gradient.

- P.D does not require carrier, is not saturable, and shows low structural specifity.

- The vast majority(about 90%) of drugs are absorbed by this process.

- Water soluble drugs penetrate the C.M through aqeous channels.

- Lipid soluble drugs readily move across most biological membranes due to solubility in the membrane lipid bilayers.

(2) Facilitated diffusion :

• It is the form of carrier transport that does not require expenditure of energy.

- These carrier proteins undergo conformational changes , allowing the passage of drugs or endogenous mollecule into the interior of the cells.

- doesn’t require energy and can be Saturated and may be inhibited by the compounds that compete for the carrier.

(3) Active transport :

• This process require special carrier protein and in this drugs move from lower concentration to high concentration with the expenditure of energy.

- The driving force for this process is ATP.

- capable of moving drugs against concentration gradient.

- Active transport systems are selective and may be compitatively inhibited by other cotransported substances.

(4) Endocytosis and Exocytosis :

• Endocytosis involves engulfment of the drug by the cell membrane and transport into the cell by pinching-off drug filled vesicle.

- This type of absorption used to transport drugs of exceptionally large size across the cell membrane.

- Vitamin B12 transport across gut wall by endocytosis.

• Exocytosis is reverse of endocytosis and many cells used this process to secrete substance out of the cell by pinching off drug filled vessicle.

- Neurotransmitter are stored in intracellular vessicles in the nerve terminal are release by exocytosis.

(B) Factors influencing absorption

(1) Effect of pH on drug absorption :

• Most drugs are either weak acids or weak bases.

•Acidic drugs(HA) release proton (H+), causing an charged anion (A-) to form :

HA <=> (H+) + (A-)

• Weak bases (BH+) can also release an H+. However protonated form of basic drugs is charged and loss of proton produce the uncharged base (B) :

BH+ <=> B + H-

- A drug passes through membrane more readily if it is uncharged.

- thus for the weak acid, the uncharged, protonated HA can permeate through membranes, and A- cannot.

- for a weak base, the uncharged form B penetrates through the cell membrane, but the protanated form BH+ doesnot.

=> Therefore effective concentration of the permeable form of each drug at its absorption site is determined by relative concentration of charged and uncharged ions.

(2) Blood flow to the absorption site :

•The intestine recieve much more blood flow than the stomach so the absorption from intestine is fvoured over stomach.

(3) Total surface area available for absorption :

• With the surface rich in brush borders containing microvilli, the intestine has surface area about 1000 times that of stomach, making absorption of the drug across the intestine more effecient.

(4) Contact time at absorption surface :

• If the drug moves through GI tract very quickly, as can happen with severe diarrhea then it will not well absorbed.

- conversly anything that delay the transport of drug from stomach to the intestine delays the rate of absorption.

- The presence of food in the stomach both dilutes the deug and slows gastric emptying. Therefore a drug taken with meal is generally absorbed more slowly.

(5) Expression of P- glycoprotein :

• It is the transmembrane transporter protein responsible for transporting various mollecule, including drugs, across the cell membrane.

- It is involved in transport of drugs from tissues to blood. Means it pumps the drug out of the cell.

- In area of higher expression, P-glycoprotein reduces drug absorption. In addition to transporying many drugs out of the cells. And it is also associated with multidrug resistance.

(C) BIOAVAILABILITY

• Bioavailability is the rate and extent to which an administered drug reaches systemic circliation.

For Ex: if 100 mg if drug is adminisyered orally and 60 mg is absorbed unchanged , the bioavailabilty is 0.6 or 60%.

- Determinig bioavailability is important for calculating drug dosages for non-intravenous routes of administration.

(i) Determination of B.A :

• It can be done by plotting a graph between plasma drug concentration versus time. One can measure area under curve (AUC), this curve reflect the absorption of the drug. This AUC is compared with AUC of IV injection i.e 100%.

Bioavailabilty = (AUC Oral / AUC of IV) x 100

- Bioavailability of certain routes are :

• Oral, inhalation = 5 to <100

• IV = 100%

• IM, subcutaneous = 75 to <100

• Rectal = 30 to 100%

(ii) Factor that influence the bioavailability :

• Orally administered drugs often undergo first pass metabolism.

- The biotransformation in addition to chemical amd physical characteristics of the drug, determines the rate and extent to which the agent reaches the systemic circulation.

(a) First pass effect :

When the drug is given through enteral route it has to pass through liver via portal circulation and then its enters general circulation so the amount of unchanged drug entering the sytemic circulation decreases, this is referred as first pass effect.

(b) Solibility of the drug : Very hydropholic drugs are poorly absorbed because of the inability to cross the lipid rich cell membrane.

- Paradoxically drugs that are lipophilic are poorly absorbed. b/c they are insoluble in aqeous body fluids and there fore cannot gain the access to the surface if cell.

- for a drug to be readily absorbed, it must ne largely lipophilic, yet have some solubility in aqueous solutions.

(c) Chemical stability : Some drugs such as pencillin G are unstable in the pH of gastric contents. Others such as insulin is destroyed by degradative enzymes in GI tract, which decrese Bioavailability.

(d) Nature of drug formulation : Drug absorption may be altered by factors unrelated to the chemistry of the drug.

For example: particle size, salt form, crystal polymorphism & enteric coating, can influence the ease of dissolution and therefore alter the rate of absorption.

(D) BIOEQUIVALENCE :

• The equivalence of blood concentration of two preparation of same drug, measured over time provided that ghey are given of same route and similar dosage.

- one drug can be safely substituted by other drug b/c both have same bioavailability.

(E)THERAPEUTIC EQUIVALENCE:

• If two similar drugs have comparable efficacy and safety, then they are known to be in the therapeutic equivalence.

- Therapeutic equivalence requires that drug products are bioequivalent and pharmacietically equivalent.

Comments

Autonomic Nervous System Anatomy and Physiology

The Autonomic Nervous System • The Autonomic Nervous System(ANS) along with endocrine system coordinates the regulation amd integeration of body functions. •The ANS largerly independent (autonomous) in that its activities are not under direct conscious control. It is concenred primarily with visceral functions such as cardiac output, blood flow to various organs and digestions, which is necessary for life. • Drugs that produce their primary therpeutic effect by mimicking or altering the functions of ANS are called autonomic drugs. - The autonomic agents act either by stimulating portion of ANS or by blocking the action of autonomic nerves . Nervous System overview : • The N.S is divided into 2 anatomical divisions : The Central Nervous System which is composed of brain & spinal cord and the Peripheral Nervous System . • Peripheral nervous system includes neurons which located outside the brain and spinal cord. • The peripheral nervous syste

AGONIST & ANTAGONIST with types

AGONIST • Agonist is a chemical(drug) that binds to the receptor and activates the receptor to produce biological response. OR • Agonist is a drug that produce effects on endogenous compounds, when it interacts with it’s receptor. => Agonists are of following types: (1) Full agonists (2) Partial agonists (3) Inverse agonists (1) Full Agonists • If a drug binds to a receptor and produce maximal biological response that mimics the response to endogenous ligand is called full agonist. - All full agonists for a receptor population should produce the same E max. For Example : phenylephrine is a full agonist at alpha1-adrenoceptors, because it produce the same E max as the endogenous ligand, norepinephrine. Upon binding with aplha1-adrenoceptors on vascular smooth muscle, both phenylephrine and norepinephrine stablize the receptor in its active state, thereby increasing the Gq activation. Activation of Gq i

Elimination of the Drug

Drug Elimination • Drugs must be sufficiently polar to be eliminated from the body. • Removal of drugs from body occur via number of routes; the most important is elimination through kidney in to urine. Renal Elimination of Drug • A drug passes through several process in the kidney before elimination, Glomerular filtration, tubular seceration , and passive tubular reabsorption. (1) Glomerular filteration : • Drugs enter the kidney through renal artries, which divide to form a glomerular capillary plexus. Free drug (not bound to albumin) flows through the capillary bed into bowman’s space as a part of glomerular filterate. > Glomerular filteration rate is normally about 120mL/min. But may decrease sugnificantly in renal disease. > pH and lipid solubility do not influence the passage of drugs into glomerular filterate. > Variation in GFR and protein binding to drugs donot affect this process. > water and polar compounds easily enter in gl

Cholinergic neuron & Cholinergic Receptors

•Drugs affecting the autonomic nervous system(ANS) are divided into two groups according to the type of neuron involved in mechanism of action. •The cholinergic drugs, which act on receptors activated by acetylcholine(Ach), Where as adrenergic drugs act on receptors stimulated by epinephrine or norepinephrine. •The cholinergic drugs act by either stimulating or blocking the receptors of the ANS. The cholinergic neuron • The preganglionic fibres terminating in adrenal medulla. • The postganglionic fibres of parasympathetic division use ACh as a neurotransmitter. The postganglionic sumpayhetic division of sweat glands also uses ACh. • Ina ddition, cholinergicneurons innervate the muscles of somatic system and play an important role in CNS. NEUROTRANSMISSION @ CHOLINERGIC NEURON : • Neurotransmission at cholinergic neurons involves 6 sequential steps : (1) Synthesis of ACh (2) Storage of ACh (3) Release of ACh (4) Binding of ACh to the receptor (5) Degradati

Cholinergic Drugs (direct acting) Part-2

(3) CARBACHOL (Carbamylcholine ) • Carbachol is is an ester of carbamic acid and poor substrate for AChEsterase. It is biotransformed by other esters at very slow rate. • Carbachol has both Muscarinic and Nicotinic actions. Functions (i) Actions : • Carbachol has profound effects on both Cardiovascular system and GI system. • It has ganglion stimulating activity and it may first stimulate and then depress these systems. • It can cause release of epinephrine from adrenal medulla by its nicotinic functions. On Eye : • It cause miosis • It cause spasm of accomodatiom in which the ciliary muscle of the eye remains in a constant state of contraction. • Carbachol is also used to stimulate micturation by contraction of detrusor muscle. (ii) Therapeutic uses : • Carbachol has high potency, receptor non-selectivity and relatively long duration of action. • Carbachol is rarely used. • Carbachol administered ocularly to induce miosis to reduce the intr

PHARMACODYNAMICS & Drug Receptor Interaction

>Pharmacodynamics deals with the biochemical and physiological effect of drug as well as its mechanism of action. OR We can simply define it as, The action of drug on the body. •Most drug exert effects, both beneficial and harmful, by interacting with specialized target macromollecule called receptor. Receptor : it refers to the drug binding site in the cell or on the surface of cell which mediate the action of drug. • There are some drugs which do not require receptors Example = mannitol , anti-helmintic drugs, etc. NATURE OF DRUG RECEPTOR 1. Regulatory protein which mediates the action of endogenous chemical signals. For example : neurotransmitters , harmones and autocoids. 2. Enzymes. For example : dihydrofolic reductase 3. Transport protein. For example : sodium / potassium ATPase pump. 4. Structural protein. For example : tubulin. RECEPTOR REGULATION •Down Regulation : when receptors becom

Cholinergic Drugs (Direct acting) Part-1

Cholinergic Agonists (direct acting) • Cholinergic agonists mimic the effect of acetylcholine by binding directly to cholinoceptors (muscarinic & nicotinic). • These agents are classified into 2 groups; (1) Choline esters : it includes endogenous ACh and synthetic esters of choline. Such as Carbachol & Bethanechol . (2) Naturally occuring Alkaloids : Nicotine & Pilocarpine . • All direct-actings Cholinergic drugs have longer duration of action than Acetylcholine. (1) ACETYLCHOLINE • ACh is the quaternary ammonium compound that cannot penetrates membranes. • It is nuerotransmitter of parasympathetic, somatic nerves & autonomic ganglia. • It lacks the therapeutics importance b/c of multiple actions and its rapid inactivation by the cholinesterases. • ACh has both muscarinic and nicotinic activity. Functions : (a) Decrease in heart rate and cardiac output : • ACh mimics the effects of vagal stimulation on the heart. • If in

Drug clearance & Half Life & Dose

Drug Clearance It refers to the ratio of rate of drug elimination to the concentration of drug in biological fluid(C). CL = rate of elimination / C Rate of elimination • For most of the drugs, elimination is not saturable & rate of drug elimination is directly proportional to concentration. Rate of elimination = CL x C ==> The difference between drug clearance and drug elimination is that : • Clearance is Volume of blood cleared of drug per unit time and Elimination is amount of drug cleared from blood per unit time. Total Body Clearance • The total body systemic clearance , CLtotal is the sum of all clearances from drug metabolising and drug eliminating organs. OR • Dividing the rate of elimination at each organ by concentration of drug presented to it yeilds respective clearance at that organ and sum of these is total body clearance. CLx = rate of elimination x / C

Drug Clearance by Biotranformation

Drug clearance : Once a drug enters into the body, the process of elimination begins. The three major routes of eliminations are: (i) Hepatic metabolism (ii) Biliary elimination (iii) Urinary excreation Excreation is irreversible removal of the drug from the body. It involves BIOTRANSFORMATION & EXCREATION. •> Metabolism results in products with increase polarity, which allows the drug to be eliminated. •> Clearance(CL) estimates the vomume of blood from which the drug is cleared per unit of time. CL = 0.693 x V d / t 1/2 - W here T 1/2 is the elimination half life, Vd is apparent volume of distribution and 0.693 is natural log. BIOTRANSFORMATION • The general principle of biotransformation is the metabolic conversion of drug mollecule to more water soluble metabolites that are more readily excreated. - In many cases, metabolism of drug results in its conversion to compounds that have little or no pharmacological activity

Search This Blog